Ms. Stephanie Kenney's most recent trade in Atrium Therapeutics Inc. was a trade of 2,375 Common Stock done at an average price of $8.9 . Disclosure was reported to the exchange on Sept. 18, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atrium Therapeutics Inc | Ms. Stephanie Kenney | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.95 per share. | 18 Sep 2026 | 2,375 | 33,085 | - | 8.9 | 21,256 | Common Stock |
| Atrium Therapeutics Inc | Ms. Stephanie Kenney | See Remarks | 20 Apr 2026 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | ||
| Atrium Therapeutics Inc | Ms. Stephanie Kenney | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 30,000 | 35,460 | - | 0 | Common Stock |